Suchergebnisse - "Lu, Yong-Chen"

PubPharm (169)

101

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

enthalten in: Europäisches Patentamt | 2019

von YOSEPH RAMI | LU YONG-CHEN | CAFRI GAL | +1

102

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

enthalten in: Europäisches Patentamt | 2019

von YOUSEPH RAMI | LU YONG-CHEN | CAFRI GAL | +1

103

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

enthalten in: Europäisches Patentamt | 2019

von YOSEPH RAMI | LU YONG-CHEN | CAFRI GAL | +1

104

항-KRAS-G12D T 세포 수용체

enthalten in: Europäisches Patentamt | 2019

von TRAN ERIC | LU YONG CHEN | PASETTO ANNA | +3

105

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2019

von Goff, S. | Morgan, R. | Yang, J. | +14

106

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

enthalten in: Nature communications | 2019

von Cafri, G. | Yossef, R. | Pasetto, A. | +12

107

Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

enthalten in: Cancer immunology research | 2019

von Lo, W. | Parkhurst, M. | Robbins, P. | +15

108

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

enthalten in: Nature medicine | 2018

von Zacharakis, N. | Chinnasamy, H. | Black, M. | +15

CommentIn: Nat Med. 2018 Jun;24(6):703-704. - PMID 29867234

109

HLA-CW8 제한된 돌연변이 KRAS를 인식하는 T 세포 수용체

enthalten in: Europäisches Patentamt | 2018

von TRAN ERIC | LU YONG CHEN | ROSENBERG STEVEN A

110

HLA-CW8 제한된 돌연변이 KRAS를 인식하는 T 세포 수용체

enthalten in: Europäisches Patentamt | 2018

von TRAN ERIC | LU YONG CHEN | ROSENBERG STEVEN A